Adhera Therapeutics, Inc. Quarterly Nonoperating Income (Expense) in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Adhera Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2010 to Q3 2023.
  • Adhera Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2023 was -$3.27M, a 160% decline year-over-year.
  • Adhera Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2023 was -$3.21M, a 61.2% decline year-over-year.
  • Adhera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$496K, a 91.3% increase from 2021.
  • Adhera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$5.68M, a 228% decline from 2020.
  • Adhera Therapeutics, Inc. annual Nonoperating Income (Expense) for 2020 was -$1.73M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$3.21M -$3.27M -$2.01M -160% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$1.2M $567K +$19K +3.47% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q1 2023 -$1.22M -$533K -$719K -387% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-22
Q4 2022 -$496K $25.8K +$1.49M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$1.99M -$1.26M +$2.25M +64.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$4.24M $548K +$933K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-21
Q1 2022 -$5.17M $186K +$504K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 -$5.68M -$1.47M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$3.51M -$3.16M -917% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$385K +$165K +30% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$318K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 -$345K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 -$550K -$549K -54900% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q2 2019 -$1K* +$879K +99.9% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q2 2018 -$816K -$880K -$658K -296% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$158K -$145K -$30K -26.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$128K $145K +$2.01M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$2.14M $63.8K +$64.2K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
Q2 2017 -$2.2M -$222K +$59.7K +21.2% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 -$2.26M -$115K -$2.18M -106% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-18
Q4 2016 -$78.6K -$1.86M Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$378* -$2.49M -100% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$282K -$2.21M -115% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-15
Q1 2016 $2.07M +$339K +19.6% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-16
Q3 2015 $12.6M $2.49M +$8.01M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-21
Q2 2015 $4.62M $1.93M -$2.67M -58.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $7.29M $1.73M +$10.2M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$2.96M $6.48M +$8.51M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$11.5M -$5.52M -$4.42M -401% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$7.05M $4.59M +$4.41M +2465% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$11.5M -$8.52M -$10.2M -600% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$1.25M -$2.03M +$502K +19.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-18
Q3 2013 -$1.75M -$1.1M -$1.04M -1764% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 -$706K $179K -$1.43M -88.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-19
Q1 2013 $722K $1.7M +$2.35M Jan 1, 2013 Mar 31, 2013 10-Q 2014-08-19
Q4 2012 -$1.62M -$2.53M -$4.54M -226% Oct 1, 2012 Dec 31, 2012 10-K 2014-08-05
Q3 2012 $2.91M -$59K -$1.3M -105% Jul 1, 2012 Sep 30, 2012 10-Q 2014-08-07
Q2 2012 $4.21M $1.61M -$257K -13.8% Mar 31, 2012 Jun 30, 2012 10-Q 2014-08-07
Q1 2012 $4.47M -$644K -$2.25M -140% Jan 1, 2012 Mar 31, 2012 10-Q 2014-08-07
Q4 2011 $6.71M $2.01M Oct 1, 2011 Dec 31, 2011 10-K 2014-07-22
Q3 2011 $1.24M -$1.28M -50.8% Jul 1, 2011 Sep 30, 2011 10-Q 2012-12-05
Q2 2011 $1.86M -$187K -9.12% Apr 1, 2011 Jun 30, 2011 10-Q 2012-12-05
Q1 2011 $1.6M Jan 1, 2011 Mar 31, 2011 10-Q 2012-12-05
Q3 2010 $2.51M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $2.05M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.